{"name":"Mega Lifesciences","slug":"mega-lifesciences","ticker":"MEGA.BK","exchange":"SET","domain":"megawecare.com","description":"Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods. The company operates through three segments: Brands, Distribution, and Original Equipment Manufacture. It offers wellness and nutrition products, including medical and sports nutrition, general well-being, vitamins, probiotics, herbal medicines, and cough and cold medicines, as well as hair, kid's, men's, and women's care products; and various health concerns products, such as allergy, bone and joint, gut, liver, diabetic, eye, heart, brain, sleep and anxiety, pain, and skin care, as well as blood circulation and memory. The company also provides prescription medicines for anti-allergic, anti-infective, cardiovascular system, central nervous system, dermatology, diabetes, gastrointestinal, gynecology, nephrology, oncology, ophthalmology, orthop","hq":"Samut Prakan, Thailand","founded":1993,"employees":"~1,500","ceo":"Vivek Dhawan","sector":"Branded Generics / Consumer Health","stockPrice":36.5,"stockChange":-1.25,"stockChangePercent":-3.31,"marketCap":"$984M","metrics":{"revenue":438921743.74748164,"revenueGrowth":0.1,"grossMargin":52.3,"rdSpend":0,"netIncome":59121336.776640005,"cash":143588344.22250497,"dividendYield":4.24,"peRatio":16.7,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2025-06-01","label":"Mega Lifesciences' Branded Generic patent cliff ($10.5M at risk)","drug":"Mega Lifesciences' Branded Generic","type":"patent_expiry","sentiment":"negative"},{"date":"2027-06-01","label":"Mega Lifesciences' Branded Generic patent cliff ($8.2M at risk)","drug":"Mega Lifesciences' Branded Generic","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2022-08-25","type":"earnings","headline":"Mega Lifesciences Reports 2022 Q2 Earnings","summary":"Mega Lifesciences announced its 2022 Q2 earnings, with revenue growth of 10% year-over-year.","drugName":"","sentiment":"neutral"},{"date":"2022-06-01","type":"deal","headline":"Mega Lifesciences Partners with Local Distributor in Indonesia","summary":"Mega Lifesciences partnered with a local distributor in Indonesia to expand its market presence in the country.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE56SkQxVjdYZlZ3QjFSajdRTVhHcC12b3pEN2UzNURDcGN3eHdKdl9LRGlMSkZLWjhha2NiLThiNy1QUFZjYy1veEpuYTg5Y0NMT0RKOVY1RkRDRTdUN250eA?oc=5","date":"2017-06-21","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Mega Lifesciences Public Company Limited (MEGA.BK) company profile and facts - Yahoo Finance Singapore","headline":"Mega Lifesciences Public Company Limited (MEGA.BK) company profile and facts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE4wNXlvU085WXZvMUlWcGkxUldxU0gzaEVLdUhqZkpUeUxCbkJaV0ZUS0ItQkMwZkE1NmhUcDlCSm1PWWJYTm5EUVJnM0lReXJCNFJOTzZ3?oc=5","date":"2017-05-21","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Thai Plaspac Public Company Limited (TPAC.BK) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Thai Plaspac Public Company Limited (TPAC.BK) stock price, news, quote and history","sentiment":"neutral"}],"patents":[{"drugName":"Mega Lifesciences' Branded Generic","drugSlug":"generic-name","patentNumber":"","type":"Patent Cliff","expiryDate":"2025-06-01","territory":"US","annualRevenue":10500000},{"drugName":"Mega Lifesciences' Branded Generic","drugSlug":"generic-name","patentNumber":"","type":"Patent Cliff","expiryDate":"2027-06-01","territory":"EU","annualRevenue":8199999.999999999}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Thai Nakorn Patana Public Company Limited","Berli Jucker Public Company Limited","Siam Bioscience Public Company Limited"],"therapeuticFocus":["Cardiovascular","Gastrointestinal","Respiratory"],"financials":{"source":"yahoo_finance","revenue":437457923.06794,"revenuePeriod":"2025-12-31","revenueHistory":[{"period":"2025-12-31","value":437457923.06794},{"period":"2024-12-31","value":474463087.55856},{"period":"2023-12-31","value":484884732.75112003},{"period":"2022-12-31","value":485040947.96704}],"grossProfit":228303466.94764,"grossProfitHistory":[{"period":"2025-12-31","value":228303466.94764},{"period":"2024-12-31","value":239778389.83218002},{"period":"2023-12-31","value":219399385.16896},{"period":"2022-12-31","value":217675235.48082}],"rdSpend":1740507.14048,"rdSpendHistory":[{"period":"2025-12-31","value":1740507.14048},{"period":"2024-12-31","value":1361997.54862},{"period":"2023-12-31","value":1277489.19844},{"period":"2022-12-31","value":1372758.2167}],"sgaSpend":132974151.84064001,"operatingIncome":89753526.51834,"operatingIncomeHistory":[{"period":"2025-12-31","value":89753526.51834},{"period":"2024-12-31","value":104201795.15356},{"period":"2023-12-31","value":89806062.07888},{"period":"2022-12-31","value":82898238.83634001}],"netIncome":59121336.776640005,"netIncomeHistory":[{"period":"2025-12-31","value":59121336.776640005},{"period":"2024-12-31","value":62228850.74226},{"period":"2023-12-31","value":61616358.46258},{"period":"2022-12-31","value":69311349.31234}],"eps":2.19,"epsHistory":[{"period":"2025-12-31","value":2.19},{"period":"2024-12-31","value":2.31},{"period":"2023-12-31","value":2.29},{"period":"2022-12-31","value":2.57}],"cash":132117627.39864,"cashHistory":[{"period":"2025-12-31","value":132117627.39864},{"period":"2024-12-31","value":107072698.10726},{"period":"2023-12-31","value":72873408.73996},{"period":"2022-12-31","value":75864719.85890001}],"totalAssets":487298802.05478,"totalLiabilities":171429316.35504,"totalDebt":21135931.08256,"equity":315868496.21302,"operatingCashflow":85665833.19218001,"operatingCashflowHistory":[{"period":"2025-12-31","value":85665833.19218001},{"period":"2024-12-31","value":74254082.85042},{"period":"2023-12-31","value":59569759.789560005},{"period":"2022-12-31","value":61738560.072500005}],"capex":-20625077.6419,"capexHistory":[{"period":"2025-12-31","value":-20625077.6419},{"period":"2024-12-31","value":-7955782.4434},{"period":"2023-12-31","value":-9077736.698040001},{"period":"2022-12-31","value":-9670501.086240001}],"freeCashflow":65040755.550280005,"dividendsPaid":-43134818.2708,"buybacks":null,"employees":0,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":30707019.674900003,"ebit":23397650.3528,"ebitda":25575510.62352,"period":"2025-12-31","revenue":113299383.42892,"epsBasic":null,"netIncome":17842981.12132,"rdExpense":null,"epsDiluted":null,"grossProfit":60407267.53366,"operatingIncome":24124459.2701},{"sga":34109091.46848,"ebit":19739672.55626,"ebitda":21939023.24168,"period":"2025-09-30","revenue":119859649.46106,"epsBasic":0.57,"netIncome":15281014.474480001,"rdExpense":null,"epsDiluted":0.57,"grossProfit":62680056.68658,"operatingIncome":28570965.2181},{"sga":35272542.32244,"ebit":16148887.092300002,"ebitda":18348145.01334,"period":"2025-06-30","revenue":105112865.051,"epsBasic":0.45,"netIncome":12087755.300280001,"rdExpense":null,"epsDiluted":0.45,"grossProfit":53474614.35874,"operatingIncome":18202072.0363},{"sga":32885498.37482,"ebit":16757637.87532,"ebitda":18941837.04534,"period":"2025-03-31","revenue":99186025.12696001,"epsBasic":0.52,"netIncome":13909585.880560001,"rdExpense":null,"epsDiluted":0.52,"grossProfit":51741528.36866,"operatingIncome":18856029.99384},{"sga":28215553.956860002,"ebit":23372047.383920003,"ebitda":25591404.253960002,"period":"2024-12-31","revenue":113080119.35606,"epsBasic":null,"netIncome":19771954.5605,"rdExpense":null,"epsDiluted":null,"grossProfit":60461534.69596,"operatingIncome":27098423.449980002},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-09-30","revenue":null,"epsBasic":0.44,"netIncome":null,"rdExpense":null,"epsDiluted":0.44,"grossProfit":null,"operatingIncome":null}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":36.5,"previousClose":37.75,"fiftyTwoWeekHigh":40,"fiftyTwoWeekLow":24.3,"fiftyTwoWeekRange":"24.3 - 40.0","fiftyDayAverage":34.36,"twoHundredDayAverage":33.02,"beta":0.33,"enterpriseValue":895268902.7467264,"forwardPE":12.7,"priceToBook":3.12,"priceToSales":2.24,"enterpriseToRevenue":2.04,"enterpriseToEbitda":9.18,"pegRatio":6.37,"ebitda":97524151.50663169,"ebitdaMargin":22.2,"freeCashflow":64357463.022067204,"operatingCashflow":85665833.93429504,"totalDebt":21135931.08256,"debtToEquity":6.7,"currentRatio":2.23,"returnOnAssets":12.3,"returnOnEquity":19,"analystRating":"1.5 - Strong Buy","recommendationKey":"strong_buy","numberOfAnalysts":6,"targetMeanPrice":41.83,"targetHighPrice":45,"targetLowPrice":35,"dividendRate":1.6,"payoutRatio":0.73,"fiveYearAvgDividendYield":3.88,"exDividendDate":1773014400,"insiderHeldPercent":61.4,"institutionHeldPercent":11,"sharesOutstanding":871869508,"floatShares":343830459,"sharesShort":0,"shortRatio":0,"shortPercentOfFloat":0,"epsTrailing":2.19,"epsForward":2.86,"revenuePerShare":16.28,"bookValue":11.72,"officers":[{"age":64,"name":"Mr. Vivek  Dhawan","title":"CEO, Head of ESG, Chief Coach & Executive Director"},{"age":62,"name":"Mr. Thomas  Abraham","title":"CFO, Head Coach & Executive Director"},{"age":51,"name":"Mr. Deepak  Panjwani","title":"Chief Risk & Compliance Officer"},{"age":62,"name":"Mr. Paramjit Singh Sawhney","title":"President of International & Head Coach"},{"age":55,"name":"Mr. Girish  Wadhwa","title":"President of Myanmar & Head Coach"},{"age":65,"name":"Ms. Duangnapa  Tongsiri","title":"President of Mega We Care Thailand & Head Coach"},{"age":53,"name":"Ms. Sujintana  Boonworapat","title":"Corporate Secretary"},{"age":51,"name":"Mr. Manoj  Gurbuxani","title":"Deputy Chief Financial Officer"}],"industry":"Drug Manufacturers - Specialty & Generic","irWebsite":"","website":"https://www.megawecare.com","phone":"66 2 769 4222"}}